Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Delivery of care news

Show

From To
Trump’s bid to wipe out AIDS will take more than a pill

Eradicating the virus will need to look less like a science experiment and more like a broad social welfare program.

Published
11 June 2019
From
Politico
Community based adherence clubs have higher drop-out rates than those based in clinics

Differentiated care models need further investigation to support people living with HIV with taking their antiretroviral treatment (ART).

Published
07 June 2019
From
Avert
US: Nearly 1 in 5 People Living With HIV Have Suboptimal Geographic Access to HIV Care

Nearly 10% of people living with HIV have to travel more than an hour to access HIV care, and those living in rural counties have drive times more than double that of those in urban counties.

Published
03 June 2019
From
American Journal of Managed Care
California may make anti-HIV drug available without prescription for 30 days

Democratic Sen. Scott Wiener has proposed a bill that would allow people to receive their first 30 days of PrEP over the counter if they first receive counseling and an HIV test. But the bill faces opposition from the California Medical Association, which represents doctors, and major insurance companies.

Published
02 June 2019
From
San Francisco Chronicle
In Ethiopia, A Focus on Multi-Month ART Scripting at Scale Pays Off

As ministries of health and their partners move to scale up differentiated service delivery (DSD) for HIV treatment, one approach is taking the spotlight. Multi-month scripting (MMS) is a facility-based, individual-focused DSD model, in which recipients of care who are doing well on antiretroviral therapy (ART) receive larger amounts of ART at each visit, enabling their appointments to be spaced at longer intervals. In many countries, MMS is combined with appointment spacing and fast-track approaches to minimize the amount of time that people living with HIV need to spend at health facilities.

Published
26 April 2019
From
ICAP
South Africa: Cutting U.S. funding will harm people with HIV most

Arguably the biggest challenge facing South Africa’s HIV response today is how to support many more people living with HIV to start and, importantly, stay on treatment. Doing this in the context of a dysfunctional healthcare system will not be easy, but cannot be shied away from. Yet instead of receiving commitment to do what it will take to make this happen, South Africa is facing the threat of dramatic cuts in U.S. government funding that risk derailing future progress, gambling with people’s health and lives.

Published
25 April 2019
From
Health GAP
Transgender Immigration detainee died of AIDS complications, autopsy shows

The official autopsy for Honduran migrant Roxsana Hernandez found she had "untreated HIV." Advocates say she was detained after requesting asylum. “I think this person was denied the minimum standard required by U.S. law for prisoners and detainees,” Dr. Chris Beyrer, a public health professor at Johns Hopkins University, told NBC News after reviewing the official autopsy report.

Published
24 April 2019
From
CBS News
'Stigma does not go away': Mumbai’s dedicated LGBT health clinic

After reports of transgender people being refused treatment, a new centre offers specialised services – and respite from discrimination

Published
24 April 2019
From
The Guardian
A Promising Anti-HIV Drug Poses A Dilemma

The anti-HIV drug dolutegravir is effective — but may carry a risk for pregnant women. While women in wealthy countries are given choices about their medical care, for women in poor countries the situation is different. There aren't enough doctors and nurses to explain the risks and benefits of the new drug to every patient. The country may not have the resources to keep supplies of two different drugs on the shelves. And there is no consistent access to effective birth control.

Published
23 April 2019
From
NPR
Long-Acting HIV Treatment Is Coming. Our Health Care System Needs to Prepare

New conversations are starting in HIV care as phase III trials have shown that monthly injections of cabotegravir and rilpivirine (Edurant) are non-inferior to a three-drug pill regimen. In 2018, TheBody asked a range of people living with HIV about their willingness to switch to an injectible, and most had mixed feelings. But even if there's widespread interest in this new way of taking antiretroviral therapy (and most likely also prevention, not too far away), it's important to consider not just the willingness of people to move to this new form of treatment, but whether health care systems and providers in the U.S. are ready to support this innovation.

Published
16 April 2019
From
The Body Pro
← First12345...38Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.